Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 35% ± 15% | |
peripheral blood | 18 studies | 51% ± 14% | |
brain | 12 studies | 29% ± 14% | |
intestine | 9 studies | 29% ± 15% | |
kidney | 8 studies | 26% ± 11% | |
eye | 7 studies | 28% ± 15% | |
heart | 5 studies | 24% ± 5% | |
uterus | 5 studies | 33% ± 11% | |
breast | 5 studies | 30% ± 10% | |
liver | 5 studies | 45% ± 18% | |
pancreas | 4 studies | 41% ± 13% | |
bone marrow | 4 studies | 42% ± 18% | |
prostate | 4 studies | 29% ± 14% | |
lymph node | 4 studies | 41% ± 6% | |
adipose | 4 studies | 40% ± 9% | |
skin | 3 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2788.17 | 1445 / 1445 | 100% | 15.31 | 183 / 183 |
lung | 100% | 4825.48 | 578 / 578 | 100% | 12.59 | 1154 / 1155 |
breast | 100% | 4372.41 | 459 / 459 | 100% | 10.70 | 1116 / 1118 |
intestine | 100% | 3518.35 | 966 / 966 | 100% | 10.31 | 526 / 527 |
bladder | 100% | 3426.14 | 21 / 21 | 100% | 9.92 | 503 / 504 |
uterus | 100% | 3244.32 | 170 / 170 | 100% | 9.15 | 458 / 459 |
ovary | 100% | 2300.34 | 180 / 180 | 100% | 12.26 | 429 / 430 |
stomach | 100% | 2171.17 | 359 / 359 | 100% | 12.09 | 285 / 286 |
thymus | 100% | 2786.54 | 652 / 653 | 99% | 7.40 | 600 / 605 |
kidney | 100% | 2781.80 | 89 / 89 | 98% | 9.84 | 887 / 901 |
prostate | 100% | 2565.83 | 245 / 245 | 98% | 6.37 | 494 / 502 |
brain | 96% | 1246.34 | 2541 / 2642 | 99% | 7.89 | 701 / 705 |
adrenal gland | 100% | 3005.03 | 258 / 258 | 95% | 6.60 | 219 / 230 |
skin | 100% | 3470.56 | 1807 / 1809 | 94% | 8.81 | 443 / 472 |
pancreas | 94% | 1142.99 | 307 / 328 | 98% | 9.45 | 175 / 178 |
liver | 100% | 1577.60 | 226 / 226 | 88% | 4.22 | 359 / 406 |
adipose | 100% | 5252.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4784.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.23 | 29 / 29 |
spleen | 100% | 4084.30 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.32 | 1 / 1 |
peripheral blood | 95% | 2848.32 | 882 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 1410.00 | 808 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 1018.90 | 731 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 3.26 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000301 | Biological process | negative regulation of synaptic vesicle exocytosis |
GO_0008283 | Biological process | cell population proliferation |
GO_2000114 | Biological process | regulation of establishment of cell polarity |
GO_0099010 | Biological process | modification of postsynaptic structure |
GO_0017156 | Biological process | calcium-ion regulated exocytosis |
GO_1901888 | Biological process | regulation of cell junction assembly |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0030033 | Biological process | microvillus assembly |
GO_0032486 | Biological process | Rap protein signal transduction |
GO_0045955 | Biological process | negative regulation of calcium ion-dependent exocytosis |
GO_0071320 | Biological process | cellular response to cAMP |
GO_0061028 | Biological process | establishment of endothelial barrier |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0033625 | Biological process | positive regulation of integrin activation |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0045121 | Cellular component | membrane raft |
GO_0016020 | Cellular component | membrane |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005829 | Cellular component | cytosol |
GO_0019003 | Molecular function | GDP binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0003925 | Molecular function | G protein activity |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAP1B |
Protein name | small monomeric GTPase (EC 3.6.5.2) RAP1B, member of RAS oncogene family RAP1B, member of RAS oncogene family (cDNA, FLJ79442, highly similar to Ras-related protein Rap-1b) Ras-related protein Rap-1b (EC 3.6.5.2) (GTP-binding protein smg p21B) |
Synonyms | OK/SW-cl.11 |
Description | FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. . |
Accessions | ENST00000540209.5 [P61224-3] E7ESV4 ENST00000485252.6 ENST00000341355.9 [P61224-1] F5H491 F5GZG1 F5H6R7 ENST00000542018.5 F5H500 B7ZB78 ENST00000543393.5 ENST00000542145.5 [P61224-2] ENST00000450214.6 [P61224-4] ENST00000545720.6 ENST00000538283.5 ENST00000535492.5 ENST00000540781.5 ENST00000538980.5 F8WBC0 P61224 F5GX62 F5H077 ENST00000541386.5 ENST00000537460.5 [P61224-1] ENST00000534899.5 ENST00000378985.7 ENST00000539091.5 [P61224-4] F5H4H0 ENST00000543697.5 ENST00000545270.5 ENST00000489473.6 F5H7Y6 F5GYH7 ENST00000538877.5 F5GWU8 ENST00000393436.9 [P61224-1] F5H004 ENST00000425247.6 ENST00000453560.6 ENST00000541216.1 F5GYB5 ENST00000422358.6 F5H0B7 ENST00000250559.14 [P61224-1] F5H823 ENST00000541167.5 F5H0S2 |